4
Changes in Ownership
CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-044892
Chief Scientific Officer sold 1,288 shares at $17.99 ($23,171)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pinkas Jan Chief Scientific Officer | 2026-06-22 | Sale 10b5-1 | −1,288 | $17.99 | $23,171 | 22,239 | D |
| Open-market sales · 1,288 sh · avg $17.99 · $23,171 | |||||||
Loading xslF345X06/wk-form4_1782245062.xml…